Bli Banque De Luxembourg Investments Abbott Laboratories Transaction History
Bli Banque De Luxembourg Investments
- $3.49 Trillion
- Q2 2025
A detailed history of Bli Banque De Luxembourg Investments transactions in Abbott Laboratories stock. As of the latest transaction made, Bli Banque De Luxembourg Investments holds 352,911 shares of ABT stock, worth $46.4 Million. This represents 1.36% of its overall portfolio holdings.
Number of Shares
352,911
Previous 469,221
24.79%
Holding current value
$46.4 Million
Previous $61.3 Billion
22.62%
% of portfolio
1.36%
Previous 1.86%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,602Shares Held
1.4BCall Options Held
9.23MPut Options Held
8.1M-
Vanguard Group Inc Valley Forge, PA173MShares$22.7 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$10.3 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$7.9 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.49 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $230B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...